Dublin, Ohio-based Cardinal Health has agreed to pay $8 million to resolve claims that it made payments to induce referral orders for its prescription drugs, according to a Department of Justice news release.
The case alleged that Cardinal Health violated the False Claims Act and Anti-Kickback Statute. It was filed by two whistleblowers: pharmacy owner R. Daniel Saleaumua and pharmacy consultant Kevin Rinne. Mr. Saleaumua alleged that Cardinal paid him $440,000 in exchange for purchasing Cardinal drugs.
Together, Mr. Saleaumua and Mr. Rinne will receive $760,000 of the settlement.
Read the DOJ release on Cardinal Health’s settlement.
Read about other pharmaceutical companies involved in lawsuits:
– CVS Pays $17M To Settle Medicaid Fraud Allegations
– Harvard Drug Group Pays $8M to Settle Claims of Failure to Report Suspicious Drug Orders
– Bristol-Myers Accused of Kickbacks, Bribing Physicians With Gifts
